This mornings, BioCryst (BCRX) announced that it has signed binding letters of intent with three partners to represent peramivir for flu stockpiling programs in Mexico, Brazil, China and Israel.  Mexico is where it all started, and the company says Mexico and Brazil together represent 75% of the Latin American market.  China is

Read the rest of this entry

, , , , , , , , , ,